American Brain Tumor Association National Conference Program Expanded to Include Broader Range of Tumor Types

  • SHARE
Printer Friendly

June 16, 2016

Tweet This

@theABTA expands national patient and family conference program offerings

The American Brain Tumor Association’s (ABTA) 2016 National Patient & Family Conference will feature an expanded program covering information, education, research and public policy updates on a comprehensive range of tumor types including high-grade tumors, low-grade tumors, and metastatic brain tumors.  

”With the momentum we’re seeing in brain tumor research, treatment and care, we believe this annual conference is the ideal forum in which to bring patients and families living with a brain tumor diagnosis together with world-renowned researchers and medical practitioners to hear first-hand how precision medicine is impacting the understanding and treatment of their brain tumors,” said Elizabeth Wilson, ABTA president and CEO.  

The national conference, being held in Chicago July 29-30, is the nation’s largest gathering of brain tumor patients, caregivers, healthcare professionals and researchers, attracting more than 250 attendees who come together for two days of education, support and networking opportunities.

“We are grateful for the leadership of program co-chairs Manmeet Ahluwalia, M.D., FACP, Cleveland Clinic Rose Ella Burkhardt Brain Tumor & Neuro-Oncology Center and Elizabeth B. Claus, M.D., Ph.D., Brigham and Women’s Hospital and the Yale School of Public Health, in assembling a dynamic roster of presenters who will address current and emerging issues in brain tumor research and treatment,” Wilson said.

Topics and speakers include: 

  • Metastatic brain tumors & trends in glioma - Manmeet Ahluwalia, M.D., FACP, Cleveland Clinic, program co-chair
  • WHO reclassification of glioma - Kenneth Aldape, M.D., University of Toronto
  • Surgery and brain mapping - Mitchel S. Berger, M.D., FACS, FAANS, University of California, San Francisco
  • High-Grade Tumors - E. Antonio Chiocca, M.D., Ph.D., FAANS Brigham and Women’s Hospital, Dana-Farber Cancer Institute, Harvard Medical School
  • Low-Grade Glioma Registry & Research Trends - Elizabeth B. Claus, M.D., PhD, Brigham and Women’s Hospital and Yale University School of Public Health, program co-chair
  • Genomics - David A. Reardon, M.D., Dana-Farber Cancer Institute
  • Meningioma - Galareh Zadeh, M.D., Ph.D., FRCSC, Toronto Western Hospital, University Health Network
  • Young adult and adolescent brain tumors - Jill Barnholtz-Sloan, Ph.D., Case Western Reserve University School of Medicine, Case Comprehensive Cancer Center
  • Caring for the caregiver - Jean Arzbaecher, RN, MSN, APN, University of Illinois, Chicago

The ABTA National Patient & Family Conference, “Precision Medicine and its Impact on Brain Tumors: Low Grade, High Grade and Metastatic,” will be held at the Westin O’Hare in Chicago, July 29-30, 2016. Advance registration is required by July 22, 2016: visit www.braintumorconference.org or call 800-886-ABTA (2282) or email abtacares@abta.org. A full agenda and conference schedule can be found online.

To register online, go to www.braintumorconference.org.

ABOUT THE AMERICAN BRAIN TUMOR ASSOCIATION

Founded in 1973, the American Brain Tumor Association was first and is the only national organization committed to funding brain tumor research and providing support and education programs for all tumor types for all ages.

For more information, visit www.abta.org or call 800-886-ABTA (2282).